verapamil has been researched along with Bone Loss, Osteoclastic in 7 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response curve for forskolin-induced bone mineral release (24 hrs), however, demonstrated a biphasic character, showing stimulation at 0." | 1.27 | Different roles for calcium and cyclic AMP in the action of PTH: studies in bone explants and isolated bone cells. ( Boonekamp, PM; Herrmann-Erlee, MP; Löwik, CW; van der Meer, JM; van Leeuwen, JP, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerner, U | 2 |
| Gustafson, GT | 1 |
| Redlich, K | 1 |
| Pietschmann, P | 1 |
| Stulc, T | 1 |
| Peterlik, M | 1 |
| Krieger, NS | 1 |
| Zheng, MH | 1 |
| Wood, DJ | 1 |
| Papadimitriou, JM | 1 |
| Nicholson, GC | 1 |
| Chagnac, A | 1 |
| Gazit, D | 1 |
| Zahavi, I | 1 |
| Sela, J | 1 |
| Levi, J | 1 |
| Herrmann-Erlee, MP | 1 |
| van der Meer, JM | 1 |
| Löwik, CW | 1 |
| van Leeuwen, JP | 1 |
| Boonekamp, PM | 1 |
| Fredholm, BB | 1 |
| Hänström, L | 1 |
7 other studies available for verapamil and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Inhibition of 1 alpha-hydroxy-vitamin D3 stimulated bone resorption in tissue culture by the calcium antagonist verapamil.
Topics: Animals; Bone Resorption; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Glucuronidase; H | 1982 |
Comparative study on the effect of calcium channel blockers on basal and parathyroid hormone-induced bone resorption in vitro.
Topics: Amlodipine; Animals; Bone Resorption; Calcium Channel Blockers; Gallopamil; Mice; Nifedipine; Organ | 1997 |
Demonstration of sodium/calcium exchange in rodent osteoblasts.
Topics: Animals; Biological Transport, Active; Bone Resorption; Calcium; Carrier Proteins; Cells, Cultured; | 1992 |
Evidence that protein kinase-A, calcium-calmodulin kinase and cytoskeletal proteins are involved in osteoclast retraction induced by calcitonin.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Bone Resorption; Calcitonin; Cells, Cultured | 1992 |
Effect of verapamil on bone resorption and formation in uremic rats.
Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Creatinine; Hyperparathyroidism; Kidney Failure, | 1989 |
Different roles for calcium and cyclic AMP in the action of PTH: studies in bone explants and isolated bone cells.
Topics: Animals; Bone and Bones; Bone Resorption; Calcimycin; Calcium; Cells, Cultured; Colforsin; Cyclic AM | 1988 |
Diphenylhydantoin inhibits parathyroid hormone and prostaglandin E2-stimulated bone resorption in mouse calvaria without affecting cyclic AMP formation.
Topics: Animals; Bone Resorption; Calcium; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Glyco | 1985 |